PARAMEDICS, RESEARCHERS AND WORKFORCE ANALYSTS GATHER LANDMARK PARAMEDICINE WORKFORCE DATASET Inaugural report into Australasian Paramedicine Workforce Survey report to aid workforce planning
INTERVIEWS
Dr Liz Thyer, Associate Professor in Paramedicine
School of Health Sciences, Western Sydney University &
Chief Investigator Australasian Paramedicine Workforce Survey Report 2023-2024
Alecka Miles, Community Paramedic, Dianella Family Medical Centre (WA)
Lecturer Edith Cowan University &
PhD Student Western Sydney University
John Bruning, Chief Executive Officer
Australasian College of Paramedicine
SEGMENT
Filmed in Campbelltown (NSW), Perth & Sydney | December 2024
In a milestone for paramedicine, the Australasian College of Paramedicine earlier this year released the first report of a landmark three-year study identifying and exploring trends that affect the Australasian paramedicine workforce.
The inaugural Australasian Paramedicine Workforce Survey report 2023-24 explores the demographic, career trajectory, work motivations and conditions for those working in clinical, management and educational capacities within the paramedicine workforce of Australia and Aotearoa New Zealand.
The survey findings reveal new insights into the current and future state of the paramedicine workforce across Australia and Aotearoa New Zealand and provide governments and decision-makers with crucial knowledge and evidence to better inform workforce planning.
In 2022, the College commissioned Associate Professor Liz Thyer, from Western Sydney University (WSU), as Chief Investigator to lead a team of sixteen academics and researchers from WSU, Edith Cowan University (ECU) and Auckland University of Technology (AUT). Alecka Miles (ECU) and Dr Graham Howie (AUT) led the teams from their respective universities.
Australian Health Journal spoke with Associate Professor Liz Thyer, Alecka Miles and John Bruning, Chief Executive Officer for the Australasian College of Paramedicine about the survey and the inaugural report.
Assoc Prof Liz Thyer said: “Our team includes paramedics, researchers and workforce analysts enabling us to develop a survey that gets to the core of the paramedic profession. These insights can then be used to make a better, well-supported workforce for current paramedics and those studying to enter the profession.”
The data contained in this report will assist the College, and the broader paramedicine healthcare sector, in workforce planning. As health reform across Australasia looks to more broadly engage paramedics in multidisciplinary team-based models, the survey findings aim to support all employers of paramedics in better understanding the needs of their workforce, ultimately enhancing the quality of care provided to communities across Australia and Aotearoa New Zealand.
Also captured in this segment from the College’s ACPIC conference in Sydney in September 2024 include Lucy Oatley ASM (Conference Master of Ceremonies), Intensive Care Flight Paramedic and Jemma Altmeier, Advocacy and Government Relations Manager, Australasian College of Paramedicine.
-
Detection and prevention of Alzheimer’s Disease and Related Dementias
Professor Vicky Vass serves as the Chief Executive Officer of Alzheimer’s Research Australia, which is based in Perth, Western Australia. Australian Health Journal met with Professor Vass to hear of the organisation’s mission to solve the mysteries surrounding Alzheimer’s disease, and focus on detection as the key to their efforts.
-
Recognising service in health regulation
In April 2023, Professor John Skerritt retired from his position of Deputy Secretary Health Products Regulation Group, a role he has been in since 2012. During his time at the TGA he had line responsibility for over 1200 staff involved in the regulation of therapeutic goods, regulation of gene technology and industrial chemicals and control of drug import, export and production.
At this year’s ARCS 2023 Conference, ARCS Australia CEO Dr Shanny Dyer paid tribute to Professor Skerritt and his service to the Australian health industry. She led a tribute with fellow industry heads, Elizabeth de Somer, CEO, Medicines Australia, Anne Harris, Managing Director, Pfizer Australia & New Zealand, Deon Schoombie, CEO, Consumer Healthcare Products Australia, Ian Burgess, CEO, Medical Technology Association of Australia and Arthur Brandwood, President ARCS Australia.
-
Cardiovascular Disease Risk Guidance and Calculator get long overdue update
Cardiovascular disease (CVD) is responsible for significant morbidity and premature mortality in Australia. Ischaemic heart disease was the leading cause of death in 2020 and cerebrovascular disease was the third most common cause of death.
As the first major update to Australian CVD risk assessment guidelines in over a decade, the 2023 Australian Guideline for assessing and managing cardiovascular disease risk and associated Aus CVD Risk Calculator reflect the latest evidence on assessing, communicating, and managing CVD risk. Developed using Australian-specific data and the latest evidence, it supersedes the 2012 Guidelines for the management of absolute cardiovascular disease risk.
